Page 35

20Ways Winter2014 Hospital Edition

20WAYS TO IMPROVE PATIENT CARE & PHARMACY COST CONTAINMENT Innovative Hospital Solutions by Fagron Through Fagron’s convenient, time-saving compounding solutions, you can provide tailor-made pharmaceutical patient care in just minutes. WINTER 2014 I HEALTH SYSTEM • INFUSION 33 National Sales Manager: Mark Kieren Founded: 1980 Employees: 60+ Toll-free Phone: (800) 423-6967 Fax: (800) 339-1596 Address: 2400 Pilot Knob Road St. Paul, MN 55120 Website: Order online at fagron.us Company Background Fagron, Inc. provides pharmacists in the United States with high quality compounding products and solutions. Fagron continuously introduces innovative products based on research done in our own R&D center. We work together with pharmacists, universities, physicians, and other healthcare providers to deliver optimized products and solutions. We continuously perform studies on our products, dedicated to providing you with innovative compounding solutions. Based in St. Paul, MN, Fagron, Inc. is part of the Fagron Group, the global market leader in pharmaceutical compounding, headquartered in the Netherlands. With over 1,300 employees in 30 countries worldwide, the Fagron Group provides over 200,000 pharmacists with superior compounding products every day. Product Overview n Omeprazole + SyrSpend® SF Cherry Alka Kit An all-in-one kit for omeprazole suspension compounding -It is that easy! We proudly offer an all-in-one kit for compounding: a pleasant tasting omeprazole suspension. Ready in minutes, the Omeprazole + Syrspend® SF Cherry Alka Kit provides you all the tools for preparation and administration. The simple addition of the omeprazole powder and 100 mL of water gives you an ideal alternative for patients with difficulty swallowing. Your benefits: • Time saving, simple compounding process • No more weighing – minimizes compounding errors • Contains no sugar, alcohol, sorbitol, or gluten • Proven stability of 60 days1 Additional Product Modules n SyrSpend® SF Family of Products The SyrSpend® SF family of products is an innovative line of oral suspension vehicles. This unique line of products is sugar- and alcohol-free, and is formulated to minimize GI upset and laxative effects. Active Suspending Technology™ holds particles in suspension longer to allow for more accurate dosing. • SyrSpend® SF is an all-in-one suspending vehicle buffered to a pH of 4.2 for maximum compatibility with active pharmaceutical ingredients (APIs). • SyrSpend® SF Alka is an easy-to-use powder for reconstitution that provides an alkaline environment for acid-labile drugs such as omeprazole. Stability studies are being performed continuously to provide you with extended beyond-use dating. Currently available studies include: omeprazole, vancomycin, oseltamivir, propranolol, metronidazole benzoate, gabapentin, verapamil, and ursodiol in SyrSpend® SF. n LETS KIT Convenience Pack LETS – a solution of lidocaine, epinephrine, tetracaine, and sodium metabisulfite – is an economical, proven2, innovative, safe2, and effective2 alternative to provide rapid topical anesthesia without the use of a controlled substance. The easy-to-use Fagron LETS KIT simplifies the compounding process by offering a convenient package containing all the ingredients. With the addition of water, each kit is designed to make 100 milliliters of anesthetic solution. Compact packaging allows the kits to be stacked easily for quick access and inventory control. n Drug Shortages Solutions Fagron carries a wide range of active pharmaceutical ingredients (APIs) to help you get through drug shortages. Our high quality APIs can be used to compound capsules, oral solutions, topical preparations, and parental preparations (USP <797>). Before switching your patients to alternative therapies, Fagron is your go-to source when it comes to drug shortages. Literature: 1: Whaley PA, Voudrie MA, Sorenson B. Stability of Omeprazole in SyrSpend® SF Alka (reconstituted). International Journal of Pharmaceutical Compounding. 2012; 16(2): p. 164-166. 2: Schilling CG, Bank DE, et al., Tetracaine, Epinephrine (Adrenalin), and Cocaine (TAC) Versus Lidocaine, Epinephrine, and Tetracaine (LET) for Anesthesia of Lacerations in Children, Ann. Emerg. Med., 1995, 25:2, pp203-208.


20Ways Winter2014 Hospital Edition
To see the actual publication please follow the link above